Spots Global Cancer Trial Database for omeprazole
Every month we try and update this database with for omeprazole cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 | NCT03267680 | Cervical Squamo... Vulvar High Gra... | Cyclophosphamid... Indomethacin IRX-2 Laboratory Biom... Multivitamin Omeprazole Placebo Therapeutic Con... | 25 Years - | University of Southern California | |
| Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors | NCT03864042 | Advanced Solid ... Metastatic Mela... | losartan dextromethorpha... caffeine omeprazole midazolam rosuvastatin bupropion immed... encorafenib binimetinib modafinil | 18 Years - | Pfizer | |
| Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects | NCT01517399 | Solid Tumors | tivantinib omeprazole s-warfarin caffeine vitamin K digoxin midazolam | 18 Years - | Daiichi Sankyo | |
| A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer | NCT00210470 | Squamous Cell C... | IRX-2 Cyclophosphamid... Indomethacin Zinc Omeprazole | 18 Years - 80 Years | Brooklyn ImmunoTherapeutics, LLC | |
| Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients | NCT03028103 | Diffuse Large B... Primary Mediast... Mantle Cell Lym... Advanced Solid ... Marginal Zone L... | Tazemetostat Fluconazole Omeprazole Repaglinide | 18 Years - | Ipsen | |
| Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects | NCT04108676 | Advanced Solid ... | Fluzoparib Omeprazole | 18 Years - 50 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Effect of G17DT in Patients With Stage II/III Colorectal Cancer | NCT02518373 | Colorectal Canc... | G17DT Omeprazole | 18 Years - | Cancer Advances Inc. | |
| Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients | NCT03028103 | Diffuse Large B... Primary Mediast... Mantle Cell Lym... Advanced Solid ... Marginal Zone L... | Tazemetostat Fluconazole Omeprazole Repaglinide | 18 Years - | Ipsen | |
| The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid | NCT00001191 | Gastrinoma Zollinger Ellis... | Pantoprazole Omeprazole | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers | NCT05438303 | Healthy Volunte... | AZD9833 Midazolam Omeprazole Dabigatran Etex... Celecoxib | 50 Years - 70 Years | AstraZeneca | |
| A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy | NCT06378398 | Colorectal Neop... | Omeprazole Aspirin | 18 Years - 75 Years | University of Michigan Rogel Cancer Center | |
| BAY73-4506 Probe Substrate Study | NCT01287598 | Neoplasms | Regorafenib (St... Warfarin Omeprazole Midazolam Rosiglitazone | 18 Years - | Bayer | |
| Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers | NCT05438303 | Healthy Volunte... | AZD9833 Midazolam Omeprazole Dabigatran Etex... Celecoxib | 50 Years - 70 Years | AstraZeneca | |
| A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib | NCT04959266 | Advanced Solid ... | Adavosertib Itraconazole Rifampicin Omeprazole | 18 Years - 130 Years | AstraZeneca | |
| A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. | NCT06383338 | Hodgkin Lymphom... Non Hodgkin Lym... | Omeprazole Dextromethorpha... | 6 Years - 25 Years | Murdoch Childrens Research Institute | |
| Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy | NCT02595372 | Cancer of the B... | Omeprazole | 18 Years - | Indiana University | |
| A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. | NCT06383338 | Hodgkin Lymphom... Non Hodgkin Lym... | Omeprazole Dextromethorpha... | 6 Years - 25 Years | Murdoch Childrens Research Institute | |
| A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer | NCT02013453 | Cancer of Head ... | Omeprazole Carboplatin 5FU Paclitaxel Pemetrexed | 18 Years - | University of Michigan Rogel Cancer Center | |
| A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer | NCT00210470 | Squamous Cell C... | IRX-2 Cyclophosphamid... Indomethacin Zinc Omeprazole | 18 Years - 80 Years | Brooklyn ImmunoTherapeutics, LLC | |
| Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) | NCT02950259 | Breast Neoplasm Breast Neoplasm... Triple Negative... | Cyclophosphamid... Indomethacin Omeprazole Multivitamin | - | Providence Health & Services | |
| Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach | NCT00002682 | Lymphoma | Amoxicillin Bismuth Subsali... Clarithromycin Metronidazole H... Omeprazole Tetracycline Hy... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach | NCT00003617 | Gastric Cancer | chlorambucil clarithromycin omeprazole tinidazole | 16 Years - | National Cancer Institute (NCI) | |
| Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus | NCT01465113 | Short Segment B... Long Segment Ba... | Omeprazole Vitamin D3 Vitamin D3 upper endoscopy Metformin | 18 Years - | Case Comprehensive Cancer Center | |
| Effect of a Proton Pump Inhibitor on the PK of Tepotinib | NCT03531762 | Healthy | Tepotinib Omeprazole | 18 Years - 55 Years | Merck KGaA, Darmstadt, Germany | |
| Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study | NCT01566474 | Barrett's Esoph... | Omeprazole Melatonin | 18 Years - 80 Years | Aragon Institute of Health Sciences | |
| High Dose Omeprazole in Patients With Pancreatic Cancer | NCT04930991 | Exocrine Pancre... | Omeprazole | 18 Years - 99 Years | University of Oklahoma | |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors | NCT01218620 | Adult Solid Neo... | Gamma-Secretase... Ketoconazole Rifampin Midazolam Hydro... Omeprazole Tolbutamide Dextromethorpha... Pharmacological... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates | NCT01911728 | Pharmacokinetic... Castration Resi... | MDV3100 Pioglitazone Warfarin Omeprazole Midazolam | 18 Years - | Astellas Pharma Inc | |
| The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients | NCT05680870 | Chemotherapy In... | Omeprazole | 18 Years - 65 Years | Tanta University | |
| Pharmacokinetic Drug-Drug Interaction Study of Rucaparib | NCT02740712 | Neoplasms | Caffeine Warfarin Omeprazole Midazolam digoxin Vitamin K Rucaparib | 18 Years - | pharmaand GmbH | |
| A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy | NCT06378398 | Colorectal Neop... | Omeprazole Aspirin | 18 Years - 75 Years | University of Michigan Rogel Cancer Center | |
| IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 | NCT03267680 | Cervical Squamo... Vulvar High Gra... | Cyclophosphamid... Indomethacin IRX-2 Laboratory Biom... Multivitamin Omeprazole Placebo Therapeutic Con... | 25 Years - | University of Southern California | |
| Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) | NCT02950259 | Breast Neoplasm Breast Neoplasm... Triple Negative... | Cyclophosphamid... Indomethacin Omeprazole Multivitamin | - | Providence Health & Services | |
| Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma | NCT00003151 | Lymphoma | bismuth subcitr... amoxicillin clarithromycin metronidazole h... omeprazole tetracycline hy... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Effect of a Proton Pump Inhibitor on the PK of Tepotinib | NCT03531762 | Healthy | Tepotinib Omeprazole | 18 Years - 55 Years | Merck KGaA, Darmstadt, Germany | |
| Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy | NCT02595372 | Cancer of the B... | Omeprazole | 18 Years - | Indiana University | |
| Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors | NCT01596647 | Advanced Solid ... | caffeine diclofenac omeprazole midazolam TKI258 | 18 Years - | Novartis | |
| Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma | NCT00003151 | Lymphoma | bismuth subcitr... amoxicillin clarithromycin metronidazole h... omeprazole tetracycline hy... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
